Clinical Research on Orphan Drugs

The Orphan Drug clinical exploration program provides orphan status to medicines and biologics which are defined as those intended for the treatment, forestalment or opinion of a rare complaint or situation, which is one that disturb lower than persons. We can see momentous progress in the development of treatments for rare conditions, also known as orphan medicines. Especially the agency authorized 32 new medicines and biologics with title named as orphan medicines

    Related Conference of Clinical Research on Orphan Drugs

    May 19-20, 2025

    3rd World Congress on Infectious and Contagious Disease

    Rome, Italy
    May 22-23, 2025

    6th International Conference on Immunology and Radiotherapy

    Toronto, Canada
    June 23-24, 2025

    19th International Conference on European Immunology

    Paris, France
    July 24-25, 2025

    20th International Conference on Allergic Diseases and Clinical Immunology

    Paris, France
    August 18-19, 2025

    13th International Conference on Cancer & Tumor Immunology

    Rome, Italy
    August 26-27, 2025

    6th International conference on Vaccines, Vaccination and Immunization

    Paris, France
    October 16-17, 2025

    39th International Conference on Immunology

    Amsterdam, Netherlands

    Clinical Research on Orphan Drugs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in